Business Description
Minapharm Pharmaceuticals
ISIN : EGS380G1C011
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.51 | |||||
Equity-to-Asset | 0.39 | |||||
Debt-to-Equity | 1.1 | |||||
Debt-to-EBITDA | N/A | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | N/A/9 |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 29.14 | |||||
9-Day RSI | 29.45 | |||||
14-Day RSI | 28.95 | |||||
6-1 Month Momentum % | -9.58 | |||||
12-1 Month Momentum % | -0.64 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.14 | |||||
Quick Ratio | 0.85 | |||||
Cash Ratio | 0.54 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.82 | |||||
Forward Dividend Yield % | 0.82 | |||||
5-Year Yield-on-Cost % | 0.82 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
FCF Margin % | -33.48 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | N/A | |||||
PE Ratio without NRI | N/A | |||||
PS Ratio | 0.57 | |||||
PB Ratio | 0.72 | |||||
Price-to-Tangible-Book | 0.81 | |||||
Price-to-Operating-Cash-Flow | 20.97 | |||||
EV-to-EBIT | 15.04 | |||||
EV-to-EBITDA | 9.01 | |||||
EV-to-Revenue | 1.11 | |||||
EV-to-FCF | -3.32 | |||||
Earnings Yield (Greenblatt) % | 6.65 | |||||
FCF Yield % | -52.93 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Minapharm Pharmaceuticals Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil E£) | 3,892.05 | ||
EPS (TTM) (E£) | 0 | ||
Beta | 0 | ||
Volatility % | 36.56 | ||
14-Day RSI | 28.95 | ||
14-Day ATR (E£) | 11.233858 | ||
20-Day SMA (E£) | 203.278 | ||
12-1 Month Momentum % | -0.64 | ||
52-Week Range (E£) | 165.44 - 294.7 | ||
Shares Outstanding (Mil) | 12.29 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Minapharm Pharmaceuticals Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Minapharm Pharmaceuticals Stock Events
Event | Date | Price(E£) | ||
---|---|---|---|---|
No Event Data |
Minapharm Pharmaceuticals Frequently Asked Questions
What is Minapharm Pharmaceuticals(CAI:MIPH)'s stock price today?
When is next earnings date of Minapharm Pharmaceuticals(CAI:MIPH)?
Does Minapharm Pharmaceuticals(CAI:MIPH) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |